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Human aging is an inexorable biological phenomenon characterized by a progressive decrease in physiological capacity and the reduced ability to respond to environmental stresses leads to increased susceptibility and vulnerability to disease. In this sense, it is pointed out that there are fi ve common characteristics of aging in mammals: (i) increased mortality with age after maturation; (ii) changes in biochemical composition in tissues with age; (iii) progressive decrease in physiological capacity with age; (iv) reduced ability to respond adaptively to environmental stimuli with age; and (v) increased susceptibility and vulnerability to disease (Troen 2003) . At the same time, it has been proposed that aging is the consequence of cell oxidative damage, in larity in the DNA damage and repair capacity in subjects 35-39 years vs 75-80 years of age, in addition to signifi cantly higher levels of glutathione peroxidase, catalase and ceruloplasmin in a group of elderly persons. Likewise, Betti et al. (1994) reported that these authors observed no statistically signifi cant differences in DNA damage related to increase in age. Thus, the aim of the present study is to determine the relationship of age with biological markers of oxidative stress in healthy subjects from Mexico City, Mexico.
SUBJECTS AND METHODS

Subjects and design
A cross-sectional and comparative study was carried out in a sample of 249 healthy subjects: i) 25-29 years (n = 22); ii) 30-39 years (n = 24) years; iii) 40-49 years (30); iv) 50-59 years (48); v) 60-69 years (60) and vi) 70 years (n = 65). We measured lipoperoxides by thiobarbituric acid reacting substances (TBARS) assay, erythrocyte superoxide dismutase (SOD), glutathione peroxidase (GPx) and total plasma antioxidant status (TAS) with Randox Laboratories, Ltd kits.
None of the subjects studied had been taking antioxidant supplementation (vitamins or minerals) for at least 6 months previously and none smoked or had acute or chronic diseases or were receiving prescription medications. All individuals were healthy (without arterial hypertension, diabetes mellitus, or cancer) and well nourished. Older subjects ( 60 years) had body mass index (BMI) of 23. (Barrocas et al. 1995; Ervin 1998; Vellas et al. 2000) . The physical activity was similar between groups of older subjects and adult subjects; this was measured with a physical activity questionnaire (Bertoldi et al. 2006) . The subjects agreed to participate in the study after giving their informed consent. The Ethics Committee of the Universidad Nacional Autó particular the accumulation of mtDNA mutations, determined by the imbalance of the rate of reactive oxygen species production and degradation induced by the antioxidant defense systems, named oxidative stress (Camougrand and Rigoulet 2001; Barja 2004; Rizvi et al. 2006) . Harman (1956) proposed the free radicals theory, which arises from aging, as the result of accumulation of oxidative-damaged macromolecules (protein lipids, DNA) and consequently of cells and tissues as the result of the aerobic metabolism to which individuals are exposed throughout their lifetime. In this regard, it has been pointed out that there is a correlation among longevity, metabolic rate, and antioxidant protective activity. Similarly, it has been demonstrated that an increase in antioxidant enzyme expression in experimental animals produces a signifi cant increase in longevity (Wickens 2001) .
On the other hand, Sohal et al. (1995) demonstrated that overexpression of superoxide dismutase enzymes and catalase in Drosophila melanogaster produces a 30% increase in longevity accompanied by a diminution of oxidative damage to proteins. Similarly, oxidative stress has been implicated in the pathogenesis of several diseases whose incidence increases as age increases. Notwithstanding this, it is not completely established whether reactive oxygen species are the cause or the effect of aging and of certain chronic diseases. This is because in vitro studies have shown that free radicals are able to propitiate degeneration and neuronal death, but damaged tissue itself can induce reactive oxygen species production (Fukagawa 1999) .
Evidence has also demonstrated that 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels correlate negatively with the potential maximum longevity of diverse animals, in addition to the fact that oxidative damage to DNA increases according to age (Barja 2002) . In this respect, our investigation group, by means of the comet assay technique has that subjects 70 years of age compared with those aged between 60 and 69 years present nearly twice the risk for DNA damage (Mendoza-Núñez et al. 1999) .
Nonetheless, King et al. (1997) found a simi-noma de México (Zaragoza Campus) approved the research protocol for this study.
Blood sampling and preparation
Blood samples were collected by venopuncture after a 12-hr fasting period and were placed in vacutainer and siliconized test tubes containing a separating gel without additives. Heparin and ethylenedinitrilotetraacetic acid (EDTA) were used as anticoagulant agents. Blood samples containing heparin were analyzed using complete hemoglobin test protocol (including hemoglobin, hematocrit, and leukocyte counts). Likewise TBARS, TAS, SOD, GPx activities. The samples without anticoagulant agents were centrifuged at 3,500 rpm for 10 min at 15°C-20°C with a centrifuge Eppendorf 5804 (Hamburg, Germany); the serum obtained was subjected to the following tests: glucose, blood urea nitrogen (BUN), creatinine, urate, albumin, cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-C) concentrations. These tests were used as screening measurements for diagnosis of clinically healthy subjects.
From the samples with heparin, 600 μ l of the whole blood were kept for red blood cell (SOD), 100 μ l for red blood cell (GPx). Each sample later was centrifuged at 3,500 rpm during 10min at 15°C-20°C a centrifuge Eppendorf 5804 (Hamburg, Germany). From the obtained plasma 100 μ l were taken for TAS and 1,000 μ l for TBARS.
Blood and biochemical analyses
Hemoglobin levels were measured by the cyanomethahemoglobin reaction procedure (cut-off points: males, 12.17-17.26 g/dl, females, 11.48-16.25 g/dl). Hematocrit levels were assessed by the microhematocrit procedure (cut-off points: males, 38-52%, females, 36-51%). Leukocyte counts were done by the Newbauer chamber procedure (cut-off points: 3,500-10,650/mm 3 ). Glucose, urea, creatinine, urate, albumin, cholesterol, triglycerides, and HDL-C concentration levels were determined using an Autoanalyzer Vitalab Eclipse Merck (Dieren, The Netherlands). In particular, glucose levels were measured by the glucose oxidase method (cut-off points: 63-120 mg/dl), urea levels by the Berthelot urease method (cut-off points: 9.5-47 mg/dl), creatinine levels by the Jaffe method without deproteinization (cut-off points: males, 0.3-1.5 mg/dl; females, 0.3-1.3 mg/dl), and urate levels by the uricase colorimetric method (cutoff points: males, 2.9-8.88 mg/dl; females, 2.5-8.7 mg/ dl). Albumin levels were measured with the bromocresol green technique (3.23-4.03 g/dl).
Cholesterol was analyzed using CHOD-PAP technique (cut-off points: 168-200 mg/dl), triglycerides by GPO-Trinder technique (cut-off points: 89-190 mg/dl), whereas HDL was assessed using the same technique used to analyze cholesterol after precipitation of low-and very low-density lipoproteins using a phosphotungstic acid/magnesium chloride solution (cut-off points: 42-77 mg/dl).
All reagents used in biochemical tests were obtained from Randox Laboratories, Ltd. (Crumlin, Co., Antrim, UK). Cut-off points for reference values were determined at the Gerontologic Clinical Research Laboratory of Universidad Nacional Autonoma de México (UNAM), Zaragoza Campus, Mexico City (Sánchez-Rodríguez et al. 1998).
Plasma TBARS
The TBARS assay was prepared as described by Jentzsch et al. (1996) . In the TBARS assay, one molecule of malondialdehyde reacts with two molecules of thiobarbituric acid (TBA) and thereby produces a pink pigment with absorption peak at 535 nm. Amplifi cation of peroxidation during the assay is prevented by the addition of the chain-breaking antioxidant, butyril hidroxy toluene (BHT).
Plasma (400 μ l) or malondialdehyde (MDA) standard (0.2-4 μ mol/l) prepared by hydrolysis of 1,1,3,3-tetramethoxypropane (Sigma Chemical Co., St. Louis, MO, USA) was mixed with 400 μ l orthophosphoric acid (0.2 mol/l) (Sigma Chemical Co.) and 50 μ l BHT (2 mmol/l) (Sigma Chemical Co.) in 12 × 72 mm tubes. A total of 50 μ l TBA reagent (0.11 mol/l in 0.1 mol/l NaOH) (Fluka Chem., Buchs, Switzerland) then has been added and the contents were mixed. Subsequently, the contents were incubated at 90°C for 45 min in a water bath. The tubes then were kept on ice to prevent further reaction. TBARS were extracted once with 1,000 μ l n-butanol (Sigma Chemical Co.). The upper butanol phase was read at 535 nm and at 572 nm to correct for baseline absorption in UV-spectrophotometer Shimadzu UV-1601 (Shimadzu, Kyoto). MDA equivalents (TBARS) were calculated by the difference in absorption at the two wavelengths and quantifi cation was done with calibration curve. Plasma TAS Antioxidant quantifi cation was done using 2, 2 ′ -azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) ( A B T S + ) r a d i c a l f o r m a t i o n k i n e t i c s ( R a n d o x Laboratories, Ltd., Crumlin Co., UK). The antioxidants present in plasma suppressed the bluish-green staining of the ABTS + cation, which was proportional to the antioxidant concentration level. The kinetics was measured at 600 nm with UV-spectrophotometer Shimadzu UV-1601 (Shimadzu).
Red blood cell SOD
The method uses xantine and xantine oxidase (XOD) to generate superoxide radicals, which react with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolim chloride to form a red formazan dye. SOD activity was measured by degree of inhibition of the reaction (Randox Laboratories Ltd.). The kinetics was measured at 505 nm with UV-spectrophotometer Shimadzu UV-1601 (Shimadzu).
Red blood cell GPx
In the presence of glutathione reductase and NADPH, the oxidation of glutathione (GSH) by cumene hydroperoxide is catalyzed by GPx. Oxidized glutathione (GSSG) is immediately converted into the reduced form with a subsequent oxidation of NADPH to NADP+ (Randox Laboratories, Ltd.). Decrease in absorbance was measured at 340 nm with UV-spectrophotometer Shimadzu UV-1601 (Shimadzu).
Statistical analysis
Data were processed by standard statistical software SPSS 14.0 (SPSS Inc., Chicago, IL, USA). Descriptive statistics are analyzed by means ± S.E. Results were analyzed using analysis of variance (ANOVA) and Tukey test post hoc. A p value < 0.05 was considered significant.
RESULTS
The results showed that LPO serum levels were signifi cantly higher in older subjects than in the younger ones of the same sex (young male, 0.305 ± 0.14 vs older male 0.385 ± 0.19, p < 0.05; young female, 0.314 ± 0.15 vs older female, 0.400 ± 4.41 μ mol/l, p < 0.05), however, signifi cant differences were not observed between sex by age group.
At the same time, GPx and TAS were signifi cantly lower in older males than in young males (GPx: young male, 7,661 ± 1,976 vs older male, 6,217 ± 2,165 UI/l, p < 0.05; TAS: young male, 1.35 ± 0.26 vs 1.19 ± 0.18 mmol/l, p < 0.05), nevertheless in females there were no signifi cant differences ( p > 0.05). The SOD activity was maintained signifi cantly without change, with aging (Table 1) .
Oh the other hand, signifi cant differences were not found in oxidative stress markers between premenopausal versus postmenopausal women: LPO, premenopausal, 309 ± 0.06 vs post- menopausal 384 ± 0.02 μ mol/l, p > 0.05; GPx, premenopausal 7,700 ± 482 vs postmenopausal 6,580 ± 383 UI/l, p > 0.05; TAS, premenopausal 1.18 ± 0.08 vs postmenopausal 1.13 ± 0.03 mmol/l, p > 0.05; SOD, premenopausal 176 ± 4.0 vs postmenopausal 171 ± 2.9 UI/l, p > 0.05.
In the ANOVA by age group, the LPO showed an age-related increase, in the post-hoc Tukey analysis it was found differences in the comparison of the groups of 25-29 years with 60-69 and 70 years (25-29 years, 0.22 ± 0.11 vs 60-69 years, 0.38 ± 0.18, p < 0.01, and 70 years, 0.42 ± 0.19 μ mol/l, p < 0.001). At the same time, TAS activity presented an age-related decrease, which was observed in the post-hoc analysis in the comparison among groups of 25-29 years with 60-69 and 70 years (25-29 years, 1.4 ± 0.31 vs 60-69 years, 1.1 ± 0.21, p < 0.05, and 70 years, 1.1 ± 0.22 mmol/l, p < 0.05). Also GPx showed an age-related decrease, which was observed in the post-hoc analysis in the comparison among groups of 25-29 years with 60-69 and 70 years (25-29 years, 7,966 ± 1,813 vs 60-69 years, 6,193 ± 2,235, p < 0.001, and 70 years, 6,547 ± 2,307 UI/l, p < 0.001), however, SOD activity was similar in all groups (Table 2) . Fig. 1 shows a signifi cant increase of LPO in subjects 60 years in comparison with 25-29 years group, and at the same time an age-related decrease of total antioxidant status and GPx, although there are no signifi cant differences between groups < 60 years in these parameters. The SOD activity in erythrocytes does not show any age-related changes.
DISCUSSION
During old age, generation of free radicals increases. Such a biochemical alteration increases the risk of oxidative damage to macromolecules (DNA, proteins, carbohydrates, and lipids), favoring the presence or complications of a great number of acute and chronic diseases including the following diseases: diabetes mellitus, atherosclerosis; distinct cancer types; chronic obstructive pulmonary disease, bronchial asthma, cataracts, macular degeneration, human immunodefi ciency virus (HIV)-associated infection, rheumatoid arthritis, Alzheimer's disease, obstructive sleep apnea, acute myocardial infarct, cerebrovascular disease, ischemia-reperfusion, sepsis, renal insuffi ciency, pancreatitis, and periodontal disease (Knight 1999) .
Human cells suffer from 10,000 hits of free radicals daily. This number increases with aging, and joined to certain pro-oxidant factors such as smoking, alcoholism, environmental contamination, ultraviolet radiation, insuffi cient hours of sleep, extenuating physical activity, inadequate nutrition, masculine gender, drug consumption, and psychological stress determine the genesis of chronic diseases during old age (Ames et al. 1993; Hicks et al. 1996; D'Almeida et al. 1998 ; Mastaloudis et al. 2001; Mendoza-Núñez et al. 2001) .
In this study, we found plasma LPO levels were signifi cantly higher in the group of elderly persons, as compared with the younger group. These fi ndings coincide with those reported by Özbay and Dülger (2002) . Nevertheless, it has also been reported that free radical levels do not increase according to age when no pro-oxidant factors such as smoking are associated (Bridges et al. 1993) . In this respect, both studies are crosssectional, therefore it is necessary to carry out longitudinal studies to corroborate the infl uence of aging per se on free radicals levels considering the dynamic infl uence of all pro-oxidant factors linked with lifestyles and environment.
There is evidence that effi ciency of the anti-oxidant system decreases after 45 years of age (Jones et al. 2002) . However, our data did not show a signifi cant age-related progressive increase of oxidative stress in subjects of < 60 years. We found a signifi cant diminution in GPx and anti-oxidant levels in persons > 60 years in comparison with group of 25-29 years, which agrees with the increase in LPO levels, suggesting that older subjects have higher risk of oxidative stress than younger and consequently greater vulnerability for the presence of chronic-disease in old age.
The age-related changes in SOD activity are controversial. Andersen et al. (1997) reported the age-related decrease in SOD activity, whereas Mariani et al. (2006) showed an erythrocyte SOD activity was higher in nonagenarians than subjects of 60-89 years. The present study showed that the SOD activity remains unchanged during aging. This could be because of an adaptive process that develops in the population residing in Mexico City, where the population is exposed to the environmental contamination (Medina-Navarro et al. 1997) .
In present study signifi cant differences were not observed in the biological markers of oxidative stress by sex, which is contradictory to several studies (Christensen et al. 2001; Habif et al. 2001) . Gender is a profound determinant of aging and lifespan, however, little is known about gender differences in free radical homeostasis. Oxidative stress is proposed as a key element in the multifactorial process of aging and it is predicted that the gender that lives longer must have lower levels of oxidative stress. Several hypotheses have been proposed for sex differences in longevity, including the active female immune function, the protective effect of estrogen, compensatory effects of the second X chromosome, reduction in the activity of growth hormone and the insulin-like growth factor 1 signaling cascade, and the infl uence of oxidative stress on aging and disease (Christensen et al. 2001; Austad 2006) . Bednarek-Tupikowska et al. (2004) showed that postmenopausal women have higher LPO and lower TAS than the control group. We performed a comparison between biological markers of oxidative stress of premenopausal versus postmenopausal women; the LPO levels were higher and GPx activity lower in the postmenopausal than premenopausal women, although the differences were not signifi cantly. This suggests that hormonal factor per se does not have signifi cant infl uence on oxidative stress.
It is indispensable to establish parameters that allow differentiating degrees of oxidative stress, because the oxidative stress does not necessarily represent a disease risk on account of the fact that free radicals also possess a physiological function (Finkel and Holbrook 2000; Dröge 2002 ). Thus, it would be advantageous to differentiate between aging on account of oxidative stress and moderate or severe oxidative stress, which could be useful as biological marker of chronic-disease and accelerate aging.
On the other hand, the preventive indication of antioxidant supplements, such as vitamins A, C, and E, lipoic acid, and melatonin (Kripke et al. 1998; Savitha and Panneerselvam 2007) , in healthy individuals of 45 years or more is not justifi ed, considering the fact that before 60 years old there was no signifi cant increase in oxidative stress.
Finally, our data suggest that aging per se increases oxidative stress, although it does not affect all parameters, which may refl ect the differences in the environmental and lifestyle factors of the studied subjects. It must be considered as limitations of the study that this is a crosssectional study with older adults who are survivors and are not representative of all older people. Therefore, it is necessary to carry out cross-longitudinal studies in cohorts to confi rm our fi ndings.
